TANG CAPITAL MANAGEMENT LLC

Holdings History for CytomX Therapeutics, Inc. - Common Stock, $0.00001 par value per share (CTMX)

Symbol: CTMX on Nasdaq
Investment type: Equity / Common Stock, $0.00001 par value per share
Latest Disclosed Shares Owned: 0 shares
Security Ownership %: 0%

Shares, Excluding Options vs Price

Value, Excluding Options

TANG CAPITAL MANAGEMENT, LLC ownership in CytomX Therapeutics, Inc. Common Stock, $0.00001 par value per share (CTMX)

17 Feb 2026 - TANG CAPITAL MANAGEMENT, LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 0 shares of CytomX Therapeutics, Inc. Common Stock, $0.00001 par value per share (CTMX). This represents 0% ownership of the company. In their previous filing dated 14 Aug 2025, TANG CAPITAL MANAGEMENT LLC had reported owning 11,065,662 shares, indicating a decrease of +100%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
TANG CAPITAL MANAGEMENT, LLC	0%	-100%	$0	0	-11,065,662	-100%	$4.30	13G/A	31 Dec 2025	17 Feb 2026, 16:15
TANG CAPITAL MANAGEMENT, LLC	7%	-18%	$27,442,842	11,065,662	+4,347,837	+65%	$2.48	13G/A	30 Jun 2025	14 Aug 2025, 16:15
TANG CAPITAL MANAGEMENT, LLC	8.4%		$4,769,656	6,717,825			$0.71	13G/A	31 Mar 2025	15 May 2025, 16:15

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025		-1.4%	$0	0	-11,065,662	-100%	$5.43	Q4 2025
30 Sep 2025	1.4%	0%	$35,299,462	11,065,662	0		$3.19	Q3 2025
30 Jun 2025	1.3%	+0.5%	$25,119,053	11,065,662	+4,347,837	+65%	$2.27	Q2 2025
31 Mar 2025	0.24%	-0.02%	$4,271,193	6,717,825	-593,935		$0.64	Q1 2025
31 Dec 2024	0.5%	-0.03%	$7,531,113	7,311,760	-500,000	-6.4%	$1.03	Q4 2024
30 Sep 2024	0.66%	+0%	$9,217,877	7,811,760	+19,824	+0.25%	$1.18	Q3 2024
30 Jun 2024	0.97%	+0.17%	$9,506,162	7,791,936	+1,341,936	+21%	$1.22	Q2 2024
31 Mar 2024	1.5%	-0.02%	$14,061,000	6,450,000	-100,000	-1.5%	$2.18	Q1 2024
31 Dec 2023	0.94%	+0.01%	$10,152,500	6,550,000	+100,000	+1.6%	$1.55	Q4 2023
30 Sep 2023	1.2%	-0.03%	$8,320,500	6,450,000	-150,000	-2.3%	$1.29	Q3 2023
30 Jun 2023	1.7%	+0.13%	$11,352,000	6,600,000	+506,968	+8.3%	$1.72	Q2 2023
31 Mar 2023	1.4%	+0.58%	$9,200,478	6,093,032	+2,582,587	+74%	$1.51	Q1 2023
31 Dec 2022	0.82%	+0%	$5,616,712	3,510,445	+10,445	+0.3%	$1.60	Q4 2022
30 Sep 2022	0.62%	+0.43%	$5,075,000	3,500,000	+2,445,327	+232%	$1.45	Q3 2022
30 Jun 2022	0.29%	+0.29%	$1,930,000	1,054,673	+1,054,673	NEW	$1.83	Q2 2022
31 Mar 2022		-0.13%	$0	0	-152,345	-100%	$5.43	Q1 2022
31 Dec 2021	0.13%	+0.13%	$660,000	152,345	+152,345	NEW	$4.33	Q4 2021
31 Dec 2020		-0.14%	$0	0	-112,880	-100%	$5.43	Q4 2020
30 Sep 2020	0.14%	-0.23%	$751,000	112,880	-187,120	-62%	$6.65	Q3 2020
30 Jun 2020	0.24%	0%	$2,499,000	300,000	0		$8.33	Q2 2020
31 Mar 2020	0.32%	+0.32%	$2,301,000	300,000	+300,000	NEW	$7.67	Q1 2020

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.